{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:05:58Z","timestamp":1790424358472,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1111\/jth.15765","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T05:33:20Z","timestamp":1653111200000},"page":"1818-1829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-2691","authenticated-orcid":false,"given":"Monica","family":"Sacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-2694","authenticated-orcid":false,"given":"Alessio","family":"Branchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Tardugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betti","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-8849","authenticated-orcid":false,"given":"Raimondo","family":"De Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15765_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0038-1646168","article-title":"von Willebrand factor: structure and function","volume":"70","author":"Meyer","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0015","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15765_bb0020","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry"},{"key":"10.1111\/jth.15765_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/jth.15765_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/rth2.12064","article-title":"Current issues in diagnosis and treatment of von Willebrand disease","volume":"2","author":"Keesler","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0035","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15765_bb0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15765_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650567","article-title":"Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease \u2013 results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH","volume":"76","author":"Mazurier","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15765_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15765_bb0065","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0070","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM\u20101VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0075","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jth.12885","article-title":"Shear stress\u2010independent binding of von Willebrand factor\u2010type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance","volume":"13","author":"Wohner","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0080","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1538-7836.2007.02572.x","article-title":"Clearance mechanisms of von Willebrand factor and factor VIII","volume":"5","author":"Lenting","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0085","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jth.14473","article-title":"Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates","volume":"17","author":"Lunghi","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0090","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1055\/s-0040-1714214","article-title":"Common genetic variants in ABO and CLEC4M modulate the pharmacokinetics of recombinant FVIII in severe hemophilia A patients","volume":"120","author":"Garcia\u2010Martinez","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0095","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin\u20102 regulates VWF\u2010FVIII complex half\u2010life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15765_bb0100","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0105","first-page":"45","article-title":"The asialoglycoprotein receptor minor subunit gene contributes to pharmacokinetics of factor VIII concentrates in hemophilia A","volume":"75","author":"Lunghi","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0110","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1074\/jbc.M808689200","article-title":"The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6\u2010galactose","volume":"284","author":"Steirer","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15765_bb0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","article-title":"Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance","volume":"112","author":"de Maistre","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12380","article-title":"Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies","volume":"20","author":"Costa\u2010Pinto","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15765_bb0125","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2516.2011.02499.x","article-title":"Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis","volume":"17","author":"Veyradier","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15765_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1160\/TH15-02-0119","article-title":"The D173G mutation in ADAMTS\u201013 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study","volume":"115","author":"Lancellotti","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2009.11.020","article-title":"Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS\u201013: a new prothrombotic mechanism in diseases associated with oxidative stress","volume":"48","author":"Lancellotti","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1111\/jth.15765_bb0140","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/jth.12967","article-title":"Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count","volume":"13","author":"Lancellotti","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0145","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/bloodadvances.2020002334","article-title":"Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains","volume":"4","author":"Sacco","year":"2020","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15765_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0379-0738(02)00289-X","article-title":"Paternity Testing Commission of the International Society of Forensic Genetics: recommendations on genetic investigations in paternity cases","volume":"129","author":"Morling","year":"2002","journal-title":"Forensic Sci Int"},{"key":"10.1111\/jth.15765_bb0155","article-title":"Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"key":"10.1111\/jth.15765_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2010protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1111\/jth.15765_bb0165","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein\u2010protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1111\/jth.15765_bb0170","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jth.12875","article-title":"von Willebrand factor arginine 1205 substitution results in accelerated macrophage\u2010dependent clearance in vivo","volume":"13","author":"Rawley","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0175","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African\u2010American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0180","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/s-0038-1649666","article-title":"Correlation of plasma protein C levels with cardiovascular risk factors in middle\u2010aged adults: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0185","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15765_bb0190","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.3324\/haematol.2017.168013","article-title":"Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?","volume":"102","author":"Borghi","year":"2017","journal-title":"Haematologica"},{"key":"10.1111\/jth.15765_bb0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0205","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15765_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance \u2013 biological mechanisms and clinical significance","volume":"183","author":"O'Sullivan","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15765_bb0215","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3324\/haematol.2017.175216","article-title":"Macrophage scavenger receptor SR\u2010AI contributes to the clearance of von Willebrand factor","volume":"103","author":"Wohner","year":"2018","journal-title":"Haematologica"},{"key":"10.1111\/jth.15765_bb0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2004.05275.x","article-title":"Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort","volume":"128","author":"Morange","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15765_bb0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15765_bb0230","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jmb.2015.09.024","article-title":"ResQ: an approach to unified estimation of B\u2010factor and residue\u2010specific error in protein structure prediction","volume":"428","author":"Yang","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1111\/jth.15765_bb0235","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1073\/pnas.92.14.6334","article-title":"Three\u2010dimensional structure of a cysteine\u2010rich repeat from the low\u2010density lipoprotein receptor","volume":"92","author":"Daly","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.15765_bb0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4939-0366-5_13","article-title":"Predicting the structure of protein\u2010protein complexes using the SwarmDock Web Server","volume":"1137","author":"Torchala","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1111\/jth.15765_bb0245","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/prot.24369","article-title":"A Markov\u2010chain model description of binding funnels to enhance the ranking of docked solutions","volume":"81","author":"Torchala","year":"2013","journal-title":"Proteins"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15765","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622020773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622020773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:36:15Z","timestamp":1761536175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622020773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1538783622020773"],"URL":"https:\/\/doi.org\/10.1111\/jth.15765","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}